Startups have the imprint of the times they are born in. And so was SpiceHealth, which was launched in November 2020 at the height of the first wave of the Covid-19 pandemic in the country. Naturally, the spotlight was on making affordable healthcare facilities available to people.
The brand’s origin lay in the pandemic. A basic RT-PCR test costing Rs 2,499 was simply unaffordable for the average Indian citizen. Besides, the test was only available at select locations with reports taking multiple days, sometimes weeks to arrive. The upshot was lack of timely treatment and ultimately heavy casualties.
Through SpiceHealth, Avani Singh launched India’s first NABL-accredited mobile test laboratory. This 40-foot-long container lab was capable of testing over 3,000 samples per day. The mobile lab was backed by a strong IT infrastructure which helped report results within six hours instead of a few days.
Singh worked closely with the central and state governments, and within a year SpiceHealth had 18 labs in ten locations around the country. It offered RT-PCR testing at Rs 499, an 80 per cent discount on the existing price.
“My passion for impact led me to entrepreneurship. I knew I had to do more to play my part in helping millions of my fellow citizens. Today, I am proud to say that through SpiceHealth, I have been able to touch the lives of over 5 million Indians so far,” says Singh, CEO, SpiceHealth.
Bootstrapped initially by the promoters, SpiceHealth closed its first financial year FY20-21 with revenues of Rs 791.7 million and is on track to finish FY21-22 with Rs 2200 million in revenues.
Post-Covid, the brand switched over to a hybrid mode by launching multiple pathology labs across the country. SpiceHealth plans to disrupt healthcare in India with a strong focus on Tier-2 and Tier-3 cities.
SpiceHealth remains firmly committed to its goal of providing affordable, accessible and quality healthcare services to every Indian.